Back to 
Woodline Partners LP
Woodline Partners LP
PVLA
6 quarters
Position history for Woodline Partners LP's holdings in Palvella Therapeutics, Inc.
Yes. Woodline Partners holds 317,517 shares of PVLA (Palvella Therapeutics), worth $48.5M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held PVLA since Q1 2025, across 6 quarterly 13F filings. PVLA is 0.2% of Woodline Partners' reported 13F portfolio.
Current Value
$48.5M
Current Shares
317,517
Total Value Change
+$43.1M
Total Shares Change
+123,350
Quarter-by-Quarter History